Cardiac Per2 Functions as Novel Link between Fatty Acid Metabolism and Myocardial Inflammation during Ischemia and Reperfusion Injury of the Heart

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Bonney, Stephanie ^a   Kominsky, Doug ^a   Brodsky, Kelley ^a   Eltzschig, Holger ^a   Walker, Lori ^a   Eckle, Tobias ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOYL COENZYME A HYDRATASE; INTERLEUKIN 6; LACTIC ACID; PER2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID METABOLISM; GENE; GENE CONTROL; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; LIPID METABOLISM; MOUSE; MYOCARDITIS; NONHUMAN; PER2 GENE; PHENOTYPE; PROTEIN FUNCTION; REPERFUSION INJURY; UPREGULATION;

ANIMALS; CYTOKINES; FATTY ACIDS; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT SCREENING ASSAYS; INFLAMMATION; LACTATES; MICE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERIOD CIRCADIAN PROTEINS; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84882620522     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071493     Document Type: Article

References (63)

1. van Amelsvoort LG, Schouten EG, Kok FJ, (2004) Impact of one year of shift work on cardiovascular disease risk factors. J Occup Environ Med 46: 699-706.
2. Kivimaki M, Virtanen M, Elovainio M, Vaananen A, Keltikangas-Jarvinen L, et al. (2006) Prevalent cardiovascular disease, risk factors and selection out of shift work. Scand J Work Environ Health 32: 204-208.
3. Harma M, (2001) Shift work and cardiovascular disease--from etiologic studies to prevention through scheduling. Scand J Work Environ Health 27: 85-86.
4. Boggild H, Knutsson A, (1999) Shift work, risk factors and cardiovascular disease. Scand J Work Environ Health 25: 85-99.
5. Akerstedt T, Knutsson A, Alfredsson L, Theorell T, (1984) Shift work and cardiovascular disease. Scand J Work Environ Health 10: 409-414.
6. Akerstedt T, Knutsson A, (1997) Cardiovascular disease and shift work. Scand J Work Environ Health 23: 241-242.
7. Tuchsen F, Hannerz H, Burr H, (2006) A 12 year prospective study of circulatory disease among Danish shift workers. Occup Environ Med 63: 451-455.
8. Curtis AM, Cheng Y, Kapoor S, Reilly D, Price TS, et al. (2007) Circadian variation of blood pressure and the vascular response to asynchronous stress. Proc Natl Acad Sci U S A 104: 3450-3455.
9. Malik M, Farrell T, Camm AJ, (1990) Circadian rhythm of heart rate variability after acute myocardial infarction and its influence on the prognostic value of heart rate variability. Am J Cardiol 66: 1049-1054.
10. Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, et al. (1987) Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 316: 1514-1518.
11. Panza JA, Epstein SE, Quyyumi AA, (1991) Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med 325: 986-990.
12. Staels B (2006) When the Clock stops ticking, metabolic syndrome explodes. Nat Med 12: 54-55; discussion 55.
13. Reppert SM, Weaver DR, (2002) Coordination of circadian timing in mammals. Nature 418: 935-941.
14. Pando MP, Morse D, Cermakian N, Sassone-Corsi P, (2002) Phenotypic rescue of a peripheral clock genetic defect via SCN hierarchical dominance. Cell 110: 107-117.
15. Bonney S, Hughes K, Harter PN, Mittelbronn M, Walker L, et al. (2013) Cardiac Period 2 in myocardial ischemia: Clinical implications of a light dependent protein. Int J Biochem Cell Biol 45: 667-671.
16. Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, et al. (2005) Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308: 1043-1045.
17. Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV, Antoch MP, (2006) Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock. Genes Dev 20: 1868-1873.
18. Wisor JP, O'Hara BF, Terao A, Selby CP, Kilduff TS, et al. (2002) A role for cryptochromes in sleep regulation. BMC Neurosci 3: 20.
19. Richards J, Gumz ML, (2012) Advances in understanding the peripheral circadian clocks. FASEB J 26: 3602-3613.
20. Marcheva B, Ramsey KM, Buhr ED, Kobayashi Y, Su H, et al. (2010) Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 466: 627-631.
21. Doi M, Takahashi Y, Komatsu R, Yamazaki F, Yamada H, et al. (2010) Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 16: 67-74.
22. Tsai JY, Kienesberger PC, Pulinilkunnil T, Sailors MH, Durgan DJ, et al. (2010) Direct regulation of myocardial triglyceride metabolism by the cardiomyocyte circadian clock. J Biol Chem 285: 2918-2929.
23. Paschos GK, Ibrahim S, Song WL, Kunieda T, Grant G, et al. (2012) Obesity in mice with adipocyte-specific deletion of clock component Arntl. Nat Med 18: 1768-1777.
24. Grimaldi B, Bellet MM, Katada S, Astarita G, Hirayama J, et al. (2010) PER2 controls lipid metabolism by direct regulation of PPARgamma. Cell Metab 12: 509-520.
25. Eckle T, Hartmann K, Bonney S, Reithel S, Mittelbronn M, et al. (2012) Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med 18: 774-782.
26. Zheng B, Larkin DW, Albrecht U, Sun ZS, Sage M, et al. (1999) The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 400: 169-173.
27. Zheng B, Albrecht U, Kaasik K, Sage M, Lu W, et al. (2001) Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 105: 683-694.
28. Eckle T, Grenz A, Kohler D, Redel A, Falk M, et al. (2006) Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 291: H2533-2540.
29. Redel A, Jazbutyte V, Smul TM, Lange M, Eckle T, et al. (2008) Impact of ischemia and reperfusion times on myocardial infarct size in mice in vivo. Exp Biol Med (Maywood) 233: 84-93.
30. Warth A, Eckle T, Kohler D, Faigle M, Zug S, et al. (2007) Upregulation of the water channel aquaporin-4 as a potential cause of postischemic cell swelling in a murine model of myocardial infarction. Cardiology 107: 402-410.
31. Koeppen M, Eckle T, Eltzschig HK, (2009) Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo. PLoS One 4: e6784.
32. Koeppen M, Harter PN, Bonney S, Bonney M, Reithel S, et al. (2012) Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury. Anesthesiology 116: 1245-1257.
33. Eckle T, Kohler D, Lehmann R, El Kasmi K, Eltzschig HK, (2008) Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 118: 166-175.
34. Eckle T, Krahn T, Grenz A, Kohler D, Mittelbronn M, et al. (2007) Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115: 1581-1590.
35. Kohler D, Eckle T, Faigle M, Grenz A, Mittelbronn M, et al. (2007) CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116: 1784-1794.
36. Eckle T, Grenz A, Laucher S, Eltzschig HK, (2008) A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 118: 3301-3315.
37. Serkova N, Fuller TF, Klawitter J, Freise CE, Niemann CU, (2005) H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int 67: 1142-1151.
38. Luo X, Zhang Y, Ruan X, Jiang X, Zhu L, et al. (2011) Fasting-induced protein phosphatase 1 regulatory subunit contributes to postprandial blood glucose homeostasis via regulation of hepatic glycogenesis. Diabetes 60: 1435-1445.
39. Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD, (2011) Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta 1813: 1333-1350.
40. Lopaschuk GD, McNeil GF, McVeigh JJ, (1989) Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir. Mol Cell Biochem 88: 175-179.
41. Murry CE, Jennings RB, Reimer KA, (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136.
42. Kim MY, Seo EJ, Lee DH, Kim EJ, Kim HS, et al. (2010) Gadd45beta is a novel mediator of cardiomyocyte apoptosis induced by ischaemia/hypoxia. Cardiovasc Res 87: 119-126.
43. Laxton RC, Hu Y, Duchene J, Zhang F, Zhang Z, et al. (2009) A role of matrix metalloproteinase-8 in atherosclerosis. Circ Res 105: 921-929.
44. Mishra A, Wang M, Schlotman J, Nikolaidis NM, DeBrosse CW, et al. (2007) Resistin-like molecule-beta is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung. Am J Physiol Lung Cell Mol Physiol 293: L305-313.
45. Volz HC, Laohachewin D, Seidel C, Lasitschka F, Keilbach K, et al. (2012) S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-kappaB signaling. Basic Res Cardiol 107: 250.
46. Jennings RB, Reimer KA, (1991) The cell biology of acute myocardial ischemia. Annu Rev Med 42: 225-246.
47. Lu H, Forbes RA, Verma A, (2002) Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277: 23111-23115.
48. Schmutz I, Ripperger JA, Baeriswyl-Aebischer S, Albrecht U, (2010) The mammalian clock component PERIOD2 coordinates circadian output by interaction with nuclear receptors. Genes Dev 24: 345-357.
49. Wu Y, Wang H, Brautigan DL, Liu Z, (2007) Activation of glycogen synthase in myocardium induced by intermittent hypoxia is much lower in fasted than in fed rats. Am J Physiol Endocrinol Metab 292: E469-475.
50. Ladilov Y, Maxeiner H, Wolf C, Schafer C, Meuter K, et al. (2002) Role of protein phosphatases in hypoxic preconditioning. Am J Physiol Heart Circ Physiol 283: H1092-1098.
51. Bray MS, Shaw CA, Moore MW, Garcia RA, Zanquetta MM, et al. (2008) Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am J Physiol Heart Circ Physiol 294: H1036-1047.
52. Silver AC, Arjona A, Walker WE, Fikrig E, (2012) The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity 36: 251-261.
53. Narasimamurthy R, Hatori M, Nayak SK, Liu F, Panda S, et al. (2012) Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proc Natl Acad Sci U S A 109: 12662-12667.
54. Gibbs JE, Blaikley J, Beesley S, Matthews L, Simpson KD, et al. (2012) The nuclear receptor REV-ERBalpha mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc Natl Acad Sci U S A 109: 582-587.
55. Eckle T, Eltzschig HK, (2011) Toll-like receptor signaling during myocardial ischemia. Anesthesiology 114: 490-492.
56. Eltzschig HK, Eckle T, (2011) Ischemia and reperfusion-from mechanism to translation. Nat Med 17: 1391-1401.
57. Timmers L, Pasterkamp G, de Hoog VC, Arslan F, Appelman Y, et al. (2012) The innate immune response in reperfused myocardium. Cardiovasc Res 94: 276-283.
58. Petrzilka S, Taraborrelli C, Cavadini G, Fontana A, Birchler T, (2009) Clock gene modulation by TNF-alpha depends on calcium and p38 MAP kinase signaling. J Biol Rhythms 24: 283-294.
59. Wang CY, Wen MS, Wang HW, Hsieh IC, Li Y, et al. (2008) Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2. Circulation 118: 2166-2173.
60. Logan RW, Zhang C, Murugan S, O'Connell S, Levitt D, et al. (2012) Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats. J Immunol 188: 2583-2591.
61. Baker RG, Hayden MS, Ghosh S, (2011) NF-kappaB, inflammation, and metabolic disease. Cell Metab 13: 11-22.
62. Gomez-Abellan P, Hernandez-Morante JJ, Lujan JA, Madrid JA, Garaulet M, (2008) Clock genes are implicated in the human metabolic syndrome. Int J Obes (Lond) 32: 121-128.
63. Haffner SM, (2006) The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97: 3A-11A.